Patents by Inventor Jack Gemmell

Jack Gemmell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides effective in the treatment of conditions requiring the removal or destruction of cells
    Patent number: 9243035
    Abstract: The embodiments are directed to peptides, compositions, and methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using compounds containing or based on peptides.
    Type: Grant
    Filed: November 26, 2013
    Date of Patent: January 26, 2016
    Assignee: NYMOX CORPORATION
    Inventors: Paul Averback, Jack Gemmell
  • PEPTIDES EFFECTIFE IN THE TREATMENT OF CONDITIONS REQUIRING THE REMOVAL OR DESTRUCTION OF CELLS
    Publication number: 20150148303
    Abstract: The embodiments are directed to peptides, compositions, and methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using compounds containing or based on peptides.
    Type: Application
    Filed: November 26, 2013
    Publication date: May 28, 2015
    Applicant: NYMOX CORPORATION
    Inventors: Paul AVERBACK, Jack Gemmell
  • Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
    Patent number: 8716247
    Abstract: The embodiments include methods of treating conditions requiring removal or destruction of cellular elements, such as benign or malignant tumors in humans, using compounds based on small peptides. The method includes, but is not limited to, administering the compounds intramuscularly, orally, intravenously, intrathecally, intratumorally, intranasally, topically, transdermally, etc., either alone or conjugated to a carrier.
    Type: Grant
    Filed: November 28, 2011
    Date of Patent: May 6, 2014
    Assignee: Nymox Corporation
    Inventors: Paul Averback, Jack Gemmell
  • Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
    Patent number: 8569446
    Abstract: The invention is directed to methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using compounds containing or based on peptides comprising a part of the amino acid sequence of a neural thread protein.
    Type: Grant
    Filed: October 11, 2012
    Date of Patent: October 29, 2013
    Assignee: Nymox Corporation
    Inventors: Paul Averback, Jack Gemmell
  • PEPTIDES EFFECTIVE IN THE TREATMENT OF TUMORS AND OTHER CONDITIONS REQUIRING THE REMOVAL OR DESTRUCTION OF CELLS
    Publication number: 20130040900
    Abstract: The invention is directed to methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using compounds containing or based on peptides comprising a part of the amino acid sequence of a neural thread protein.
    Type: Application
    Filed: October 11, 2012
    Publication date: February 14, 2013
    Inventors: PAUL AVERBACK, Jack Gemmell
  • Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
    Patent number: 8293703
    Abstract: The invention is directed to methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using compounds containing or based on peptides comprising a part of the amino acid sequence of a neural thread protein.
    Type: Grant
    Filed: July 11, 2008
    Date of Patent: October 23, 2012
    Assignee: Nymox Corporation
    Inventors: Paul Averback, Jack Gemmell
  • PEPTIDES EFFECTIVE IN THE TREATMENT OF TUMORS AND OTHER CONDITIONS REQUIRING THE REMOVAL OR DESTRUCTION OF CELLS
    Publication number: 20120114679
    Abstract: The embodiments include methods of treating conditions requiring removal or destruction of cellular elements, such as benign or malignant tumors in humans, using compounds based on small peptides. The method includes, but is not limited to, administering the compounds intramuscularly, orally, intravenously, intrathecally, intratumorally, intranasally, topically, transdermally, etc., either alone or conjugated to a carrier.
    Type: Application
    Filed: November 28, 2011
    Publication date: May 10, 2012
    Applicant: Nymox Pharmaceutical Corporation
    Inventors: Paul Averback, Jack Gemmell
  • Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
    Patent number: 8067378
    Abstract: The embodiments include methods of treating conditions requiring removal or destruction of cellular elements, such as benign or malignant tumors in humans, using compounds based on small peptides. The method includes, but is not limited to, administering the compounds intramuscularly, orally, intravenously, intrathecally, intratumorally, intranasally, topically, transdermally, etc., either alone or conjugated to a carrier.
    Type: Grant
    Filed: February 28, 2007
    Date of Patent: November 29, 2011
    Assignee: Nymox Pharmaceutical Corporation
    Inventors: Paul Averback, Jack Gemmell
  • Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
    Patent number: 7745572
    Abstract: The invention is directed to methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using compounds containing or based on peptides comprising a part of the amino acid sequence of a neural thread protein.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: June 29, 2010
    Assignee: Qualcomm Incorporated
    Inventors: Paul Averback, Jack Gemmell
  • Peptides Effective in the Treatment of Tumors and Other Conditions Requiring the Removal or Destruction of Cells
    Publication number: 20090286742
    Abstract: The invention is directed to methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using compounds containing or based on peptides comprising a part of the amino acid sequence of a neural thread protein.
    Type: Application
    Filed: June 15, 2009
    Publication date: November 19, 2009
    Applicant: NYMOX PHARMACEUTICAL CORPORATION
    Inventors: PAUL AVERBACK, JACK GEMMELL
  • Protein and its use in diagnosing Alzheimer's disease
    Patent number: 7544771
    Abstract: Embodiments are directed to a peptide and protein containing that peptide, nucleic acids, antibodies, as well assays detecting the peptide or protein, and methods of identifying patients with or at risk of developing Alzheimer's Disease and other neurodegenerative diseases.
    Type: Grant
    Filed: February 23, 2005
    Date of Patent: June 9, 2009
    Assignee: Nymox Corporation
    Inventors: Paul Averback, Jack Gemmell
  • Peptides Effective in the Treatment of Tumors and Other Conditions Requiring the Removal or Destruction of Cells
    Publication number: 20090022743
    Abstract: The invention is directed to methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using compounds containing or based on peptides comprising a part of the amino acid sequence of a neural thread protein.
    Type: Application
    Filed: July 11, 2008
    Publication date: January 22, 2009
    Applicant: Nymox Pharmaceutical Corporation
    Inventors: Paul Averback, Jack Gemmell
  • Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
    Patent number: 7408021
    Abstract: The invention is directed to methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using compounds containing or based on peptides comprising a part of the amino acid sequence of a neural thread protein.
    Type: Grant
    Filed: October 12, 2004
    Date of Patent: August 5, 2008
    Assignee: Nymox Pharmaceutical Corporation
    Inventors: Paul Averback, Jack Gemmell
  • Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
    Publication number: 20080176805
    Abstract: The embodiments include methods of treating conditions requiring removal or destruction of cellular elements, such as benign or malignant tumors in humans, using compounds based on small peptides. The method includes, but is not limited to, administering the compounds intramuscularly, orally, intravenously, intrathecally, intratumorally, intranasally, topically, transdermally, etc., either alone or conjugated to a carrier.
    Type: Application
    Filed: February 28, 2007
    Publication date: July 24, 2008
    Inventors: Paul Averback, Jack Gemmell
  • Humanized Antibody
    Publication number: 20080063598
    Abstract: Novel humanized and chimeric antibodies, humanized antibody fragments, polypeptides sequences of such antibodies and derivatives thereof that specifically bind AF-20 are provided as well as methods for their manufacture. These humanized and chimeric antibodies, antibody fragments and polypeptide sequences are useful in the treatment of cancers that express AF-20, as well as for diagnostic purposes, e.g., for in vivo imaging of tumors or cancer cells that express AF-20.
    Type: Application
    Filed: August 20, 2007
    Publication date: March 13, 2008
    Inventors: Paul Averback, Jack Gemmell
  • PEPTIDES EFFECTIVE IN THE TREATMENT OF TUMORS AND OTHER CONDITIONS REQUIRING THE REMOVAL OR DESTRUCTION OF CELLS
    Publication number: 20080027005
    Abstract: This application discloses compositions and methods for treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using compounds containing or based on multimeric peptides.
    Type: Application
    Filed: May 31, 2007
    Publication date: January 31, 2008
    Inventors: Paul Averback, Jack Gemmell
  • Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
    Patent number: 7317077
    Abstract: The invention is directed to methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using compounds containing or based on peptides comprising a part of the amino acid sequence of a neural thread protein.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: January 8, 2008
    Assignee: Nymox Pharmaceutical Corporation
    Inventors: Paul Averback, Jack Gemmell
  • Method of preventing or reducing the risk or incidence of cancer
    Publication number: 20070237780
    Abstract: The Embodiments Disclosed Herein are Directed to Methods of preventing or reducing the risk or incidence of cancer in a tissue, gland, organ, or other cellular mass of a mammal by removing or destroying unwanted cells therefrom using compounds containing or based on peptides described herein.
    Type: Application
    Filed: March 12, 2007
    Publication date: October 11, 2007
    Inventors: Paul Averback, Jack Gemmell
  • Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
    Patent number: 7241738
    Abstract: The present invention relates to peptides, compositions, and methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using proteins (and peptides derived from the amino acid sequences of such proteins), the amino acid sequence of which includes at least one amino acid sequence derived from neural thread proteins and other related molecules.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: July 10, 2007
    Assignee: Nymox Pharmaceutical Corporation
    Inventors: Paul Averback, Jack Gemmell
  • Protein and its use in diagnosing Alzheimer's disease
    Publication number: 20060188935
    Abstract: Embodiments are directed to a peptide and protein containing that peptide, nucleic acids, antibodies, as well assays detecting the peptide or protein, and methods of identifying patients with or at risk of developing Alzheimer's Disease and other neurodegenerative diseases.
    Type: Application
    Filed: February 23, 2005
    Publication date: August 24, 2006
    Inventors: Paul Averback, Jack Gemmell